207 related articles for article (PubMed ID: 36077200)
21. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
22. Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy.
Souidi M; Resta J; Dridi H; Sleiman Y; Reiken S; Formoso K; Colombani S; Amédro P; Meyer P; Charrabi A; Vincenti M; Liu Y; Soni RK; Lezoualc'h F; Stéphane Blot DVM; Rivier F; Cazorla O; Parini A; Marks AR; Mialet-Perez J; Lacampagne A; Meli AC
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):536-551. PubMed ID: 38221511
[TBL] [Abstract][Full Text] [Related]
23. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
25. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene.
Wang L; Li H; Li Y; Xu M; Lin J; Liao Z; Pei Z; Zhang C
Stem Cell Res; 2021 Oct; 56():102553. PubMed ID: 34619646
[TBL] [Abstract][Full Text] [Related]
26. Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.
Martyniak A; Andrysiak K; Motais B; Coste S; Podkalicka P; Ferdek P; Stępniewski J; Dulak J
J Mol Cell Cardiol; 2021 Nov; 160():128-141. PubMed ID: 34329686
[TBL] [Abstract][Full Text] [Related]
27. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.
Jin M; Wang D; Li G; Lin J; Lin X; Wang N
Stem Cell Res; 2022 Apr; 60():102718. PubMed ID: 35247844
[TBL] [Abstract][Full Text] [Related]
29. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
31. Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
Dick E; Kalra S; Anderson D; George V; Ritso M; Laval SH; Barresi R; Aartsma-Rus A; Lochmüller H; Denning C
Stem Cells Dev; 2013 Oct; 22(20):2714-24. PubMed ID: 23829870
[TBL] [Abstract][Full Text] [Related]
32. Mutations in DNAJC19 cause altered mitochondrial structure and increased mitochondrial respiration in human iPSC-derived cardiomyocytes.
Janz A; Walz K; Cirnu A; Surjanto J; Urlaub D; Leskien M; Kohlhaas M; Nickel A; Brand T; Nose N; Wörsdörfer P; Wagner N; Higuchi T; Maack C; Dudek J; Lorenz K; Klopocki E; Ergün S; Duff HJ; Gerull B
Mol Metab; 2024 Jan; 79():101859. PubMed ID: 38142971
[TBL] [Abstract][Full Text] [Related]
33. Generation of five induced pluripotent stem cell lines with DMD/c.497G > T mutation from renal epithelial cells of a Duchenne muscular dystrophy patient and a recessive carrier parent.
Su J; Wang J; Wang L; Li T; Wang H; Shen J; Wang H; Zhang J; Lin W; Huang J; Liang P
Stem Cell Res; 2020 Dec; 49():102021. PubMed ID: 33039804
[TBL] [Abstract][Full Text] [Related]
34. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
35. Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction.
Korover N; Etzion S; Cherniak A; Rabinski T; Levitas A; Etzion Y; Ofir R; Parvari R; Cohen S
Biol Res; 2023 Jun; 56(1):34. PubMed ID: 37349842
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
[TBL] [Abstract][Full Text] [Related]
37. Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.
Guan X; Mack DL; Moreno CM; Strande JL; Mathieu J; Shi Y; Markert CD; Wang Z; Liu G; Lawlor MW; Moorefield EC; Jones TN; Fugate JA; Furth ME; Murry CE; Ruohola-Baker H; Zhang Y; Santana LF; Childers MK
Stem Cell Res; 2014 Mar; 12(2):467-80. PubMed ID: 24434629
[TBL] [Abstract][Full Text] [Related]
38. Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes.
Xiao R; Zhou M; Wang P; Zeng B; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012442
[TBL] [Abstract][Full Text] [Related]
39. The intracellular Ca2+ concentration is elevated in cardiomyocytes differentiated from hiPSCs derived from a Duchenne muscular dystrophy patient.
Tsurumi F; Baba S; Yoshinaga D; Umeda K; Hirata T; Takita J; Heike T
PLoS One; 2019; 14(3):e0213768. PubMed ID: 30875388
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
